Zhejiang Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ZHEJIANG
ZHEJIANG has twenty-four approved drugs.
There are two tentative approvals on ZHEJIANG drugs.
Summary for Zhejiang
| US Patents: | 0 |
| Tradenames: | 21 |
| Ingredients: | 21 |
| NDAs: | 24 |
Drugs and US Patents for Zhejiang
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zhejiang Jingxin | LEVETIRACETAM | levetiracetam | TABLET;ORAL | 091491-004 | Dec 14, 2010 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Zhejiang Jingxin | ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 206513-001 | Mar 1, 2019 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Zhejiang Novus Pharm | VANCOMYCIN HYDROCHLORIDE | vancomycin hydrochloride | POWDER;INTRAVENOUS, ORAL | 210274-006 | Aug 1, 2025 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
